Insider’s View: Deciphering Guardant Health Inc (GH)’s Financial Health Through Ratios

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Guardant Health Inc (NASDAQ: GH) closed at $23.52 in the last session, down -0.34% from day before closing price of $23.60. In other words, the price has decreased by -$0.34 from its previous closing price. On the day, 2.47 million shares were traded. GH stock price reached its highest trading level at $24.1 during the session, while it also had its lowest trading level at $23.27.

Ratios:

We take a closer look at GH’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.07 and its Current Ratio is at 6.40.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 04 ’24 when Joyce Meghan V. sold 100 shares for $27.87 per share. The transaction valued at 2,787 led to the insider holds 4,621 shares of the business.

Kalia Kumud bought 2,187 shares of GH for $38,963 on Mar 18 ’24. The Chief Information Officer now owns 12,722 shares after completing the transaction at $17.82 per share. On Mar 04 ’24, another insider, Joyce Meghan V., who serves as the Director of the company, sold 100 shares for $19.05 each. As a result, the insider received 1,905 and left with 4,521 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GH now has a Market Capitalization of 2893477376 and an Enterprise Value of 3248435200. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.49. Its current Enterprise Value per Revenue stands at 5.046 whereas that against EBITDA is -8.499.

Stock Price History:

Over the past 52 weeks, GH has reached a high of $37.04, while it has fallen to a 52-week low of $15.81. The 50-Day Moving Average of the stock is 2.06%, while the 200-Day Moving Average is calculated to be -1.98%.

Shares Statistics:

According to the various share statistics, GH traded on average about 2.09M shares per day over the past 3-months and 1488320 shares per day over the past 10 days. A total of 121.63M shares are outstanding, with a floating share count of 117.72M. Insiders hold about 4.31% of the company’s shares, while institutions hold 98.21% stake in the company. Shares short for GH as of 1728950400 were 13683984 with a Short Ratio of 6.55, compared to 1726185600 on 11351165. Therefore, it implies a Short% of Shares Outstanding of 13683984 and a Short% of Float of 11.59.

Most Popular